Suppr超能文献

尿 N-乙酰-β-D-氨基葡萄糖苷酶水平的变化及其在不同甲状腺激素水平下检测急性肾损伤的性能:一项前瞻性招募、观察性研究。

Variations of urinary N-acetyl-β-D-glucosaminidase levels and its performance in detecting acute kidney injury under different thyroid hormones levels: a prospectively recruited, observational study.

机构信息

Department of Intensive Care Unit of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 96 Dongchuan Road, Guangzhou 510080, Guangdong Province, People's Republic of China.

Department of Critical Care Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou 510080, Guangdong Province, People's Republic of China.

出版信息

BMJ Open. 2022 Mar 3;12(3):e055787. doi: 10.1136/bmjopen-2021-055787.

Abstract

OBJECTIVE

Changes in thyroid function will be accompanied by changes in urinary N-acetyl-β-D-glucosaminidase (uNAG) levels. Therefore, whether thyroid hormones interfere the ability of uNAG in detecting acute kidney injury (AKI) has raised concern in patients with critical illness.

DESIGN

A prospectively recruited, observational study was performed.

SETTING

Adults admitted to the intensive care unit of a grade A tertiary hospital in China.

PARTICIPANTS

A total of 1919 critically ill patients were enrolled in the study.

MAIN OUTCOME MEASURES

To investigate the variations of the ability of uNAG to detect AKI in patients with critical illness under different thyroid hormones levels (differences in area under the curve (AUC) for uNAG diagnosis and prediction of AKI with different thyroid hormones levels).

RESULTS

The bivariate correlation analysis revealed that FT3 and TT3 levels were independently associated with uNAG levels (p<0.001). FT3 and uNAG also showed correlation in multivariable linear regression analysis (p<0.001). After stratification according to the levels of FT3 or TT3, significant variation was observed in the uNAG levels with different quartiles (p<0.05). However, in patients with varying FT3 and TT3 levels, no significant difference was found in the AUCs of uNAG to detect AKI (p>0.05).

CONCLUSIONS

Even if uNAG levels varied with FT3 and TT3 levels, these hormones did not interfere with uNAG's ability to detect AKI in patients with critical illness.

摘要

目的

甲状腺功能的变化会伴随着尿 N-乙酰-β-D-氨基葡萄糖苷酶(uNAG)水平的变化。因此,甲状腺激素是否会干扰 uNAG 检测急性肾损伤(AKI)的能力,这在危重病患者中引起了关注。

设计

前瞻性招募,观察性研究。

地点

中国一家 A 级三级医院的重症监护病房。

参与者

共有 1919 名危重病患者纳入本研究。

主要观察指标

探讨不同甲状腺激素水平下(不同甲状腺激素水平下 uNAG 诊断和预测 AKI 的曲线下面积(AUC)差异),危重病患者 uNAG 检测 AKI 能力的变化。

结果

双变量相关分析显示,FT3 和 TT3 水平与 uNAG 水平独立相关(p<0.001)。FT3 和 uNAG 在多元线性回归分析中也存在相关性(p<0.001)。根据 FT3 或 TT3 水平分层后,不同四分位数 uNAG 水平存在显著差异(p<0.05)。然而,在 FT3 和 TT3 水平不同的患者中,uNAG 检测 AKI 的 AUC 无显著差异(p>0.05)。

结论

即使 uNAG 水平随 FT3 和 TT3 水平变化,这些激素也不会干扰 uNAG 检测危重病患者 AKI 的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c27e/8896032/262b63223c7b/bmjopen-2021-055787f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验